Indian Journal of Finance

Open Access Open Access  Restricted Access Subscription Access

Mergers and Acquisitions in the Indian Context : A Valuation Perspective for the Indian Pharmaceutical Industry


Affiliations
1 PGP 2019 – 2021 Student, Indian Institute of Management Shillong (IIM Shillong), Shillong, Meghalaya - 793 014, India
2 Associate Professor, Indian Institute of Management Shillong (IIM Shillong), Shillong, Meghalaya - 793 014, India

   Subscribe/Renew Journal


Mergers and acquisitions (M&A) as a strategy has been used increasingly by the corporate sector to gain a competitive advantage. Mergers and acquisitions (M&A) help a firm gain new customer bases, enter new markets, gain access to new technologies, and help achieve cost reduction. In today’s time, firms try to achieve synergistic gains through M&As. This study aimed to: a) understand if prices paid by acquiring firms reflected synergistic gains and b) observe value created for shareholders of the acquiring firms. The study used secondary data for the purpose of research. A neural network model was built to scrutinize the impact of the selected variables on the value of the mergers and acquisitions (M&A) deal. An event study was carried out to assess value creation for shareholders of the acquiring firm. The study found that an acquiring firm generally paid more during the M&As compared to the synergistic gains it realized post-acquisition. Additionally, there was no value creation for the acquiring firm’s shareholders. The neural network model from this study, with appropriate variables, can be used to predict the price of an M&A deal. The study will benefit the stakeholders of pharmaceutical firms to make informed decisions regarding mergers and acquisitions.

Keywords

Mergers And Acquisitions, Synergy Valuation, Artificial Neural Network, Pharmaceutical Sector, Event Study.

JEL Classification Codes : G34, G30, L65.

Paper Submission Date : June 5, 2021 ; Paper Sent Back for Revision : February 15, 2022 ; Paper Acceptance Date : March 15, 2022 ; Paper Published Online : April 15, 2022.

User
Subscription Login to verify subscription
Notifications
Font Size

  • Beena, S. (2006). Mergers and acquisitions in the Indian pharmaceutical industry: Nature, structure and performance (MPRA Paper No. 8144). https://mpra.ub.uni-muenchen.de/8144/1/MPRA_paper_8144.pdf

  • Chatterjee, S. (1986). Types of synergy and economic value: The impact of acquisitions on merging and rival firms. Strategic Management Journal, 7(2), 119–139. https://doi.org/10.1002/smj.4250070203

  • Damodaran, A. (2005). The value of synergy. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.841486

  • Danzon, P. M., Epstein, A., & Nicholson, S. (2007). Mergers and acquisitions in the pharmaceutical and biotech industries. Managerial and Decision Economics, 28(4–5), 307–328. https://doi.org/10.1002/mde.1343

  • Duggal, N. (2015). Post merger performance of acquiring firms: A case study on Indian pharmaceutical industry. International Journal of Research in Management & Business Studies, 2(3), 24–28. http://ijrmbs.com/vol2issue3/neha.pdf

  • Mishra, P. (2006). Mergers, acquisitions, market structure and industry performance: Experience of Indian pharmaceutical industry. Review of Development and Change, 11(2), 135–164. https://doi.org/10.1177/0972266120060202

  • Prakash, S. (2017). The impact of mergers and acquisitions on shareholders’ value: An empirical analysis of select Indian companies. Indian Journal of Finance, 11(9), 22–38. https://doi.org/10.17010/ijf/2017/v11i9/118087

  • Raghuvanshi, A., & Raghuvanshi, A. (2014). Determinants of shareholder gains in acquisitions: An empirical study in the Indian corporate sector. Indian Journal of Finance, 8(2), 37–48. https://doi.org/10.17010/ijf/2014/v8i2/71979

  • Ranju, P. K., & Mallikarjunappa, T. (2017). Do acquisitions create value for acquirer companies in India? An empirical study. Indian Journal of Research in Capital Markets, 4(1), 7–18. https://doi.org/10.17010/ijrcm/2017/v4/i1/112880

  • Sarangi, P., Sinha, D., Sinha, S., & Dubey, M. (2019). Financial modeling using ANN technologies: Result analysis with different network architectures and parameters. Indian Journal of Research in Capital Markets, 6(1), 21–33. https://doi.org/10.17010/ijrcm/2019/v6/i1/144039

  • Shelton, L. M. (1988). Strategic business fits and corporate acquisition: Empirical evidence. Strategic Management Journal, 9(3), 279 – 287. https://doi.org/10.1002/smj.4250090307

  • Tripathy, S., & Prajapati, V. (2014). Mergers and acquisitions: Trends in Indian pharmaceutical industry. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 14(4), 182–190. https://doi.org/10.1177/1745790415577854

  • Vyas, V., Narayanan, K., & Ramanathan, A. (2012). Determinants of mergers and acquisitions in Indian pharmaceutical industry. Eurasian Journal of Business and Economics, 5(9), 79–102. https://www.ejbe.org/EJBE2012Vol05No09p079VYAS-NARAYANAN-RAMANATHAN.pdf

  • Willmott, C., Ackleson, S., Davis, R., Feddema, J., Klink, K., & Legates, D., O’Donnell, J., & Rowe, C. M. (1985). Statistics for the evaluation and comparison of models. Journal of Geophysical Research, 90(C5), 8995 – 9005. https://doi.org/10.1029/jc090ic05p08995

  • Willmott, C., & Matsuura, K. (2005). Advantages of the mean absolute error (MAE) over the ischolar_main mean square error (RMSE) in assessing average model performance. Climate Research, 30, 79–82. https://doi.org/10.3354/cr030079

  • Zhu, M., & Meng, Z. (2021). Fuzzy comprehensive evaluation model of M&A synergy based on transfer learning graph neural network. Computational Intelligence and Neuroscience, 1–12. https://doi.org/10.1155/2021/6516722


Abstract Views: 221

PDF Views: 0




  • Mergers and Acquisitions in the Indian Context : A Valuation Perspective for the Indian Pharmaceutical Industry

Abstract Views: 221  |  PDF Views: 0

Authors

Chintan Gala
PGP 2019 – 2021 Student, Indian Institute of Management Shillong (IIM Shillong), Shillong, Meghalaya - 793 014, India
Mousumi Bhattacharya
Associate Professor, Indian Institute of Management Shillong (IIM Shillong), Shillong, Meghalaya - 793 014, India

Abstract


Mergers and acquisitions (M&A) as a strategy has been used increasingly by the corporate sector to gain a competitive advantage. Mergers and acquisitions (M&A) help a firm gain new customer bases, enter new markets, gain access to new technologies, and help achieve cost reduction. In today’s time, firms try to achieve synergistic gains through M&As. This study aimed to: a) understand if prices paid by acquiring firms reflected synergistic gains and b) observe value created for shareholders of the acquiring firms. The study used secondary data for the purpose of research. A neural network model was built to scrutinize the impact of the selected variables on the value of the mergers and acquisitions (M&A) deal. An event study was carried out to assess value creation for shareholders of the acquiring firm. The study found that an acquiring firm generally paid more during the M&As compared to the synergistic gains it realized post-acquisition. Additionally, there was no value creation for the acquiring firm’s shareholders. The neural network model from this study, with appropriate variables, can be used to predict the price of an M&A deal. The study will benefit the stakeholders of pharmaceutical firms to make informed decisions regarding mergers and acquisitions.

Keywords


Mergers And Acquisitions, Synergy Valuation, Artificial Neural Network, Pharmaceutical Sector, Event Study.

JEL Classification Codes : G34, G30, L65.

Paper Submission Date : June 5, 2021 ; Paper Sent Back for Revision : February 15, 2022 ; Paper Acceptance Date : March 15, 2022 ; Paper Published Online : April 15, 2022.


References





DOI: https://doi.org/10.17010/ijf%2F2022%2Fv16i4%2F169173